亚太地区人工泪液市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(纤维素源泪液、甘油源泪液、油基乳液泪液、聚乙二醇基泪液、丙二醇基泪液和透明质酸钠基人工泪液) ;给药方式(滴眼剂和药膏);应用(干眼症治疗、隐形眼镜保湿)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 137    |    Report Code: TIPRE00023486    |    Category: Life Sciences

Asia Pacific Artificial Tears Market

市场介绍

人工泪液是润滑性滴眼液,用于治疗因干眼症或泪液分泌不足引起的刺激和干燥。干燥性角结膜炎。它们还用于湿润隐形眼镜以及在眼部检查和检查期间。快速增长的老龄化人口主要促进了人工泪液市场的增长。衰老使人们更容易患干眼症等眼部疾病,从而导致对人工泪液的高需求。此外,眼科手术和眼科手术后管理数量的增加进一步推动了人工泪液市场的增长。

因此,日益增长的老年人口预计将在未来几年对人工泪液产生巨大需求,预计这将进一步推动人工泪液市场的发展。

亚太地区国家正面临着由于 COVID-19 发病率增加而带来的挑战。人们正在打包印度的公共干眼治疗,因为许多人无力承担通常坚持更高护理标准的私人治疗。疫情严重影响旅游业,造成供应链中断;此外,低收入国家由于医疗基础设施短缺而面临更多挑战。韩国、马来西亚、新加坡、菲律宾和印度已采取限制措施,以防止疾病传播。 2020年11月,专注于眼部护理市场商业化Avenova的制药公司NovaBay Pharmaceuticals, Inc.宣布与Paragon Care Group Australia Pty Ltd签署协议,在澳大利亚独家经销Avenova。 Paragon Care Group 将于 2021 年初开始以其 Designs for Vision 品牌直接向消费者销售 Avenova。Avenova 是治疗影响约 85% 干眼症患者的慢性细菌感染的最佳产品。因此,人工泪液市场因 COVID -19 受到中等程度的影响。

 

市场概况和动态

亚太地区人工泪液市场预计将从2021年的3.412亿美元增长到2028年的5.495亿美元;预计2021年至2028年复合年增长率为6.3%。干眼症的发病率常见于65岁及以上的人群。全球老年人口正在迅速增加。根据2019年修订的《世界人口展望》,到2050年,六分之一的人年龄在65岁以上,比2019年的十分之一有所增加。此外,到2050年,80岁以上的人口将从1.43亿增加到4.26亿。 2019年。衰老是导致眼睛视力减弱的突出因素之一。各种医疗保健公司都以老年人群为重点来设计其产品。由于老年人的退化过程更快,因此他们很容易出现眼部疾病。因此,老年人口中干眼症的高患病率可能会鼓励制造商在市场上推出新的眼科产品,这反过来又将有助于市场的增长。此外,医疗保健行业的发展也提高了预期寿命。世界各国正在采用新技术来安全有效地治疗老年人。因此,生活质量的提高正在降低死亡率,并且世界各地的老年人口正在显着增长。预计这将促进市场的增长。

 

主要细分市场

从类型来看,甘油衍生泪液细分市场占据2020年亚太人工泪液市场最大份额;从输送方式来看,滴眼液细分市场占据2020年亚太人工泪液市场最大份额从应用来看,2020年人工泪液市场中,干眼治疗领域占据较大市场份额。

 

主要来源和上市公司

准备本亚洲人工泪液市场报告时提到的一些主要一手和二手来源太平洋公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Johnson and Johnson Services, Inc.

Alcon Inc.

OASIS Medical

AbbVie Inc.

拜耳公司

Prestige Consumer Healthcare Inc.

参天制药有限公司、Bausch Health Companies Inc. 和 Aurolab。

 

购买报告的理由

  • 了解亚太地区人工泪液市场格局并确定最有可能保证市场份额的细分市场丰厚回报
  • 了解亚太人工泪液市场不断变化的竞争格局,保持领先地位
  • 有效规划亚太人工泪液市场的并购和合作交易确定最有希望销售的细分市场
  • 通过对亚太人工泪液市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得市场收入预测2021-2028 年亚太地区各个细分市场

 

亚太地区人工泪液市场细分

类型

  • 甘油衍生眼泪
  • 纤维素衍生眼泪
  • 油基乳液眼泪
  • 聚乙二醇类眼泪
  • 透明质酸钠类人工泪液
  • 丙二醇类眼泪
  • 透明质酸钠类人工泪液
  • 丙二醇类眼泪

 

投放方式

  • 眼药水
  • 软膏

 < /span>

 

按应用

  • 干眼睛护理
  • 隐形眼镜水分

 

按国家/地区

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太地区其他地区

 

提及的公司

  1. 强生服务公司
  2. 爱尔康公司
  3. OASIS Medical
  4. 艾伯维公司
  5. 拜耳股份公司
  6. Prestige Consumer Healthcare Inc.
  7. 参天制药有限公司
  8. Bausch Health Companies Inc.
  9. Aurolab< /li>

 

 

 

Asia Pacific Artificial Tears Strategic Insights

Strategic insights for Asia Pacific Artificial Tears involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-artificial-tears-market-strategic-framework.webp
Get more information on this report

Asia Pacific Artificial Tears Report Scope

Report Attribute Details
Market size in 2021 US$ 341.2 Million
Market Size by 2028 US$ 549.5 Million
Global CAGR (2021 - 2028) 6.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 类型
  • 纤维素泪液
  • 甘油泪液
  • 油性乳剂泪液
  • 聚乙二醇泪液
  • 丙二醇泪液
  • 透明质酸钠人工泪液
By 给药方式
  • 眼药水
  • 药膏
By 应用
  • 干眼症治疗
  • 隐形眼镜保湿
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Johnson and Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Aurolab
  • Get more information on this report

    Asia Pacific Artificial Tears Regional Insights

    The regional scope of Asia Pacific Artificial Tears refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-artificial-tears-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Artificial Tears Market

    1. Johnson and Johnson Services, Inc.
    2. Alcon Inc.
    3. OASIS Medical
    4. AbbVie Inc.
    5. Bayer AG
    6. Prestige Consumer Healthcare Inc.
    7. Santen Pharmaceutical Co., Ltd.
    8. Bausch Health Companies Inc.
    9. Aurolab

     

    Frequently Asked Questions
    How big is the Asia Pacific Artificial Tears Market?

    The Asia Pacific Artificial Tears Market is valued at US$ 341.2 Million in 2021, it is projected to reach US$ 549.5 Million by 2028.

    What is the CAGR for Asia Pacific Artificial Tears Market by (2021 - 2028)?

    As per our report Asia Pacific Artificial Tears Market, the market size is valued at US$ 341.2 Million in 2021, projecting it to reach US$ 549.5 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Artificial Tears Market report typically cover these key segments-

  • 类型 (纤维素泪液, 甘油泪液, 油性乳剂泪液, 聚乙二醇泪液, 丙二醇泪液, 透明质酸钠人工泪液)
  • 给药方式 (眼药水, 药膏)
  • 应用 (干眼症治疗, 隐形眼镜保湿)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Artificial Tears Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Artificial Tears Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Artificial Tears Market?

    The Asia Pacific Artificial Tears Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Johnson and Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Aurolab
  • Who should buy this report?

    The Asia Pacific Artificial Tears Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Artificial Tears Market value chain can benefit from the information contained in a comprehensive market report.